The Market Herald Video

" Universal Ibogaine (TSXV:IBO) announces change in leadership

Universal Ibogaine (IBO) has appointed Nick Karos as CEO on an interim basis, effective immediately. 
The Market Herald Video

" Universal Ibogaine (TSXV:IBO) announces appointment of Dr. Ian Rabb as Chief Clinics Officer

Universal Ibogaine (IBO) is pleased to announce the appointment of addiction treatment and clinic operations veteran Dr. Ian Rabb as Chief Clinics Officer.

" Clearmind Medicine (CSE:CMND) appoints distinguished addiction experts to its scientific advisory board

Clearmind Medicine (CMND) has appointed professors Wim van den Brink and Gabriele Fischer to the company’s scientific advisory board.
Levitee Labs - CEO, Pouya Farmand.

" Levitee Labs (CSE:LVT) releases positive results from revenue report

Levitee Labs (LVT) increased revenue by 10 per cent in one month.